BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 25991675)

  • 1. Identification and evaluation of network modules for the prognosis of basal-like breast cancer.
    Hallett RM; Cockburn JG; Li B; Dvorkin-Gheva A; Hassell JA; Bane A
    Oncotarget; 2015 Jul; 6(19):17713-24. PubMed ID: 25991675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IMPA2 promotes basal-like breast cancer aggressiveness by a MYC-mediated positive feedback loop.
    Lei X; Liao R; Chen X; Wang Z; Cao Q; Bai L; Ma C; Deng X; Ma Y; Wu X; Li J; Dai Z; Dong C
    Cancer Lett; 2024 Feb; 582():216527. PubMed ID: 38048842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs as Molecular Biomarkers for the Characterization of Basal-like Breast Tumor Subtype.
    Tariq M; Richard V; Kerin MJ
    Biomedicines; 2023 Nov; 11(11):. PubMed ID: 38002007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory Effort of MLN2238 on Basal-Like Breast Cancer: An Investigation Based on the Gene Set Enrichment Analysis.
    Wang D; Li Y; Luo F; Song X; Wu S; Chen Y; Zhang N
    Cell Mol Biol (Noisy-le-grand); 2023 Jul; 69(7):143-149. PubMed ID: 37715393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein A-1 downregulation promotes basal-like breast cancer cell proliferation and migration associated with DNA methylation.
    Wang C; Chen S; Zhang R; Chen M; Yang X; He Y; Shangguan Z; Mao Q; Zhang Z; Ying S
    Oncol Lett; 2024 Jul; 28(1):295. PubMed ID: 38737975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative network-based approach identifies key genetic elements in breast invasive carcinoma.
    Hamed M; Spaniol C; Zapp A; Helms V
    BMC Genomics; 2015; 16 Suppl 5(Suppl 5):S2. PubMed ID: 26040466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SPECTRA: An Integrated Knowledge Base for Comparing Tissue and Tumor-Specific PPI Networks in Human.
    Micale G; Ferro A; Pulvirenti A; Giugno R
    Front Bioeng Biotechnol; 2015; 3():58. PubMed ID: 26005672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Network topology and functional connectivity disturbances precede the onset of Huntington's disease.
    Harrington DL; Rubinov M; Durgerian S; Mourany L; Reece C; Koenig K; Bullmore E; Long JD; Paulsen JS; ; Rao SM
    Brain; 2015 Aug; 138(Pt 8):2332-46. PubMed ID: 26059655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triple-negative breast cancer: immune modulation as the new treatment paradigm.
    Disis ML; Stanton SE
    Am Soc Clin Oncol Educ Book; 2015; ():e25-30. PubMed ID: 25993181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Network-based prediction and knowledge mining of disease genes.
    Carson MB; Lu H
    BMC Med Genomics; 2015; 8 Suppl 2(Suppl 2):S9. PubMed ID: 26043920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence-based Network Completion Reveals the Integrality of Missing Reactions in Metabolic Networks.
    Krumholz EW; Libourel IG
    J Biol Chem; 2015 Jul; 290(31):19197-207. PubMed ID: 26041773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HGF and TGFβ1 differently influenced Wwox regulatory function on Twist program for mesenchymal-epithelial transition in bone metastatic versus parental breast carcinoma cells.
    Bendinelli P; Maroni P; Matteucci E; Desiderio MA
    Mol Cancer; 2015 Jun; 14():112. PubMed ID: 26041563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analyse multiple disease subtypes and build associated gene networks using genome-wide expression profiles.
    Aibar S; Fontanillo C; Droste C; Roson-Burgo B; Campos-Laborie FJ; Hernandez-Rivas JM; De Las Rivas J
    BMC Genomics; 2015; 16 Suppl 5(Suppl 5):S3. PubMed ID: 26040557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A null model for Pearson coexpression networks.
    Gobbi A; Jurman G
    PLoS One; 2015; 10(6):e0128115. PubMed ID: 26030917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noise-driven causal inference in biomolecular networks.
    Prill RJ; Vogel R; Cecchi GA; Altan-Bonnet G; Stolovitzky G
    PLoS One; 2015; 10(6):e0125777. PubMed ID: 26030907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSI: a nonparametric Bayesian approach to network inference from multiple perturbed time series gene expression data.
    Penfold CA; Shifaz A; Brown PE; Nicholson A; Wild DL
    Stat Appl Genet Mol Biol; 2015 Jun; 14(3):307-10. PubMed ID: 26030796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid Hormone Receptors Predict Prognosis in BRCA1 Associated Breast Cancer in Opposing Ways.
    Heublein S; Mayr D; Meindl A; Angele M; Gallwas J; Jeschke U; Ditsch N
    PLoS One; 2015; 10(6):e0127072. PubMed ID: 26029931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of programmed cell death 4 (PDCD4) is associated with aromatase inhibitor resistance and a poor prognosis in estrogen receptor-positive breast cancer.
    Chen Z; Yuan YC; Wang Y; Liu Z; Chan HJ; Chen S
    Breast Cancer Res Treat; 2015 Jul; 152(1):29-39. PubMed ID: 26026468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognosis of breast cancer patients after mastectomy and immediate breast reconstruction: a meta-analysis.
    Yang X; Zhu C; Gu Y
    PLoS One; 2015; 10(5):e0125655. PubMed ID: 26024490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. xHeinz: an algorithm for mining cross-species network modules under a flexible conservation model.
    El-Kebir M; Soueidan H; Hume T; Beisser D; Dittrich M; Müller T; Blin G; Heringa J; Nikolski M; Wessels LF; Klau GW
    Bioinformatics; 2015 Oct; 31(19):3147-55. PubMed ID: 26023104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.